184 - Drop it Like it’s Hot! Deprescribing Pharmacotherapy When Appropriate

HelixTalk - Rosalind Franklin University's College of Pharmacy Podcast

Вміст надано Sean P. Kane, PharmD, BCPS, Sean P. Kane, and PharmD; Khyati Patel. Весь вміст подкастів, включаючи епізоди, графіку та описи подкастів, завантажується та надається безпосередньо компанією Sean P. Kane, PharmD, BCPS, Sean P. Kane, and PharmD; Khyati Patel або його партнером по платформі подкастів. Якщо ви вважаєте, що хтось використовує ваш захищений авторським правом твір без вашого дозволу, ви можете виконати процедуру, описану тут https://uk.player.fm/legal.

6M ago 38:50

MP3•Головна епізоду

In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, memantine, antipsychotics, and antihyperglycemics.

Key Concepts

Medication appropriateness including indication and risk vs. benefit should be evaluated for all stages of life; however, more importantly in older individuals to address polypharmacy.
There is an emerging trend of deprescribing networks that conduct research and provide evidence-based recommendations for how to deprescribe certain medications used for specific indications.
Evidence-based deprescribing guidelines for PPIs, benzodiazepines, benzodiazepine receptor agonists, opioids, antipsychotics, cholinesterase inhibitors, memantine, and antihyperglycemics are available for patient-provider shared decision making.
A general deprescribing approach is gradual tapering of the drug leading to discontinuation over several weeks while monitoring patients for withdrawal symptoms or benefits of discontinuation.

References

http://deprescribing.org
https://www.australiandeprescribingnetwork.com.au

201 епізодів

#Rfums #Rosalindfranklin #Fitness #Sean P. Kane, PharmD, BCPS #PharmD; Khyati Patel #Sean P. Kane #Pharmacy #Science #Medicine #Pharmacist #Drug #PharmD #Medical